Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.44 |
| ▸ | REN | P00797 | 1/20 | 0.44 |
| ▸ | F2 | P00734 | 2/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.42 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.42 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.40 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 2/20 | 0.40 |
| ▸ | FAP | Q12884 | 2/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.40 |
| ▸ | PREP | P48147 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1170124 | 1.00 | ACE (0.44) | ACERENF2FOLH1RIMKLA | |
| SCHEMBL8255099 | 0.96 | FOLH1 (0.41) | ACERENF2FOLH1RIMKLA | |
| SCHEMBL2084204 | 0.96 | FOLH1 (0.41) | ACERENF2FOLH1RIMKLA | |
| SCHEMBL17997394 | 0.91 | F2 (0.42) | ACEF2ITGB1ITGA4DPP4 | |
| SCHEMBL28890641 | 0.91 | F2 (0.42) | ACEF2ITGB1ITGA4DPP4 | |
| SCHEMBL29832826 | 0.91 | PTPN1 (0.43) | ACERENF2CMA1ITGB1 | |
| SCHEMBL30563217 | 0.91 | GRB2 (0.42) | ACERENF2CMA1ITGB1 | |
| SCHEMBL30627048 | 0.90 | ACE (0.44) | ACERENF2CMA1ITGB1 | |
| SCHEMBL29832765 | 0.88 | PTPN1 (0.42) | F2CMA1POLBITGB1ITGA4 | |
| SCHEMBL2082150 | 0.88 | XIAP (0.43) | F2ITGB1ITGA4DPP4FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4001 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025149851-A2 | METHODS FOR TREATING INFLAMMATORY DISEASES | YUYU PHARMA, INC. (KR) | 2025-07-17 | — | — | WO | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| WO-2025042352-A2 | SINGLE-CHAIN VARIABLE FRAGMENT (SCFV) MOUSE ANTIBODY SPECIFIC TO SAPOSIN-LIKE PROTEIN 2 OF THE LIVER FLUKE FASCIOLA GIGANTICA | BURAPHA UNIVERSITY (TH) | 2025-02-27 | — | — | WO | claimed |
| EP-4493148-A1 | PROTEIN HYDROLYSATES OF AZUKI BEANS AND COSMETIC USES THEREOF | Lubrizol Advanced Materials, Inc. (US) | 2025-01-22 | — | — | EP | claimed |
| CN-117858890-A | Polypeptide compound and application thereof in treating enteritis | 四川好医生攀西药业有限责任公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117720638-A | Recombinant IV type humanized collagen with antioxidant and anti-inflammatory activities | 西安德诺海思医疗科技有限公司 | 2024-03-19 | — | — | CN | claimed |
| WO-2023175531-A1 | PROTEIN HYDROLYSATES OF AZUKI BEANS AND COSMETIC USES THEREOF | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2023-09-21 | — | — | WO | claimed |
| WO-2023080791-A1 | PEPTIDES FOR THE INHIBITION OF PARASITE INFECTION | KAPP DET GODE HÅP AS (NO) | 2023-05-11 | — | — | WO | claimed |
| CN-110003334-B | Polypeptide, CD19 single domain antibody, preparation method thereof, nucleotide sequence and kit | 深圳普瑞金生物药业股份有限公司 | 2023-05-09 | — | — | CN | claimed |
| WO-2022256800-A2 | HUMAN SPERMINE OXIDASE CRYSTAL AND USES THEREOF | JANSSEN VACCINES & PREVENTION B.V. (NL) | 2022-12-08 | — | — | WO | claimed |
| US-20150197543-A1 | Treatment of Autism Spectrum Disorders Using Glycyl-L-2-Methylprolyl-L-Glutamic Acid | NEUREN PHARMACEUTICALS LIMITED (NZ) | 2015-07-16 | — | — | US | claimed |
| CN-104302271-A | Moisturizing composition comprising an aminopeptide mixture | UNILEVER NV | 2015-01-21 | — | — | CN | claimed |
| WO-2014085480-A1 | TREATMENT OF AUTISM SPECTRUM DISORDERS USING GLYCYL-L-2-METHYLPROLYL-L-GLUTAMIC ACID | NEUREN PHARMACEUTICALS LIMITED (NZ) | 2014-06-05 | — | — | WO | claimed |
| US-20140147491-A1 | TREATMENT OF AUTISM SPECTRUM DISORDERS USING GLYCYL-L-2-METHYLPROLYL-L-GLUTAMIC ACID | NEUREN PHARMACEUTICALS LIMITED (AU) | 2014-05-29 | — | — | US | claimed |
| EP-2667715-A1 | TREATMENT OF AUTISM SPECTRUM DISORDERES USING GLYCYL-L-2-METHYLPROLYL-L-GLUTAMIC ACID | Neuren Pharmaceuticals Limited (NZ) | 2013-12-04 | — | — | EP | claimed |
| WO-2012102832-A1 | TREATMENT OF AUTISM SPECTRUM DISORDERES USING GLYCYL-L-2-METHYLPROLYL-L-GLUTAMIC ACID | NEUREN PHARMACEUTICALS LIMITED (NZ) | 2012-08-02 | — | — | WO | claimed |
| WO-2011037644-A1 | CYCLIC GLYCYL-2-ALLYL PROLINE AND ITS USE IN TREATMENT OF PERIPHERAL NEUROPATHY | NEUREN PHARMACEUTICALS LIMITED (NZ) | 2011-03-31 | — | — | WO | claimed |
| US-20110052531-A1 | CYCLIC GLYCYL-2-ALLYL PROLINE AND ITS USE IN TREATMENT OF PERIPHERAL NEUROPATHY | NEUREN PHARMACEUTICALS LIMITED (AU) | 2011-03-03 | — | — | US | claimed |
| US-7776876-B2 | Cyclic G-2Allylproline in treatment of Parkinson's disease | NEUREN PHARMACEUTICALS, LTD. (NZ) | 2010-08-17 | — | — | US | claimed |
| US-20060258663-A1 | Cyclic G-2AllylProline in treatment of Parkinson's disease | NEUREN PHARMACEUTICALS LIMITED (NZ) | 2006-11-16 | — | — | US | claimed |